XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2018
Apr. 01, 2017
Dec. 30, 2017
Operating activities:      
Net income $ 129,374 $ 238,404  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 16,014 14,658  
Amortization 7,132 7,070  
(Gain) loss on sale or disposal of property and equipment (15) 8  
Provision for doubtful accounts 57 (294)  
Provision for obsolete and slow moving inventories 3,959 7,193  
Unrealized foreign currency (gain) loss (517) 42,571  
Deferred income taxes 416 (171,432)  
Stock compensation expense 13,440 8,206  
Realized losses on marketable securities 196 291  
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable 187,693 135,253  
Inventories (26,455) (41,398)  
Other current and non-current assets 9,037 7,534  
Accounts payable (36,708) (44,180)  
Other current and non-current liabilities (99,935) (81,038)  
Deferred revenue (8,368) (12,041)  
Deferred costs 1,807 2,647  
Income taxes payable 17,063 6,943  
Net cash provided by operating activities 214,190 120,395  
Investing activities:      
Purchases of property and equipment (26,336) (25,538)  
Proceeds from sale of property and equipment 121 7  
Purchase of intangible assets (1,622) (1,222)  
Purchase of marketable securities (140,623) (96,049)  
Redemption of marketable securities 65,253 109,526  
Acquisitions, net of cash acquired (9,417)  
Net cash used in investing activities (112,624) (13,276)  
Financing activities:      
Dividends (96,146) (96,028)  
Proceeds from issuance of treasury stock related to equity awards 1,926  
Purchase of treasury stock related to equity awards (6,562) (3,452)  
Purchase of treasury stock under share repurchase plan (27,873)  
Net cash used in financing activities (100,782) (127,353)  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 6,717 6,932  
Net increase (decrease) in cash, cash equivalents, and restricted cash 7,501 (13,302)  
Cash, cash equivalents, and restricted cash at beginning of period 891,759 846,996 $ 846,996
Cash, cash equivalents, and restricted cash at end of period $ 899,260 $ 833,694 $ 891,759